O	0	7	Absence	Absence	NN	B-NP
O	8	10	of	of	IN	B-PP
O	11	21	microbiota	microbiota	NN	B-NP
O	22	23	(	(	(	O
O	23	27	germ	germ	NN	B-NP
O	27	28	-	-	HYPH	O
O	28	32	free	free	JJ	B-NP
O	33	43	conditions	condition	NNS	I-NP
O	43	44	)	)	)	O
O	45	56	accelerates	accelerate	VBZ	B-VP
O	57	60	the	the	DT	B-NP
O	61	76	atherosclerosis	atherosclerosis	NN	I-NP
O	77	79	in	in	IN	B-PP
O	80	84	ApoE	ApoE	NN	B-NP
O	84	85	-	-	HYPH	B-NP
O	85	94	deficient	deficient	JJ	I-NP
O	95	99	mice	mouse	NNS	I-NP
O	100	103	fed	feed	VBN	B-VP
O	104	112	standard	standard	JJ	B-NP
O	113	116	low	low	JJ	I-NP
O	117	128	cholesterol	cholesterol	NN	I-NP
O	129	133	diet	diet	NN	I-NP
O	133	134	.	.	.	O

O	135	138	AIM	AIM	NN	B-NP
O	138	139	:	:	:	O

O	140	143	The	The	DT	B-NP
O	144	147	aim	aim	NN	I-NP
O	148	150	of	of	IN	B-PP
O	151	154	our	our	PRP$	B-NP
O	155	159	work	work	NN	I-NP
O	160	163	was	be	VBD	B-VP
O	164	166	to	to	TO	B-VP
O	167	176	determine	determine	VB	I-VP
O	177	180	the	the	DT	B-NP
O	181	190	influence	influence	NN	I-NP
O	191	193	of	of	IN	B-PP
B-Multi-tissue_structure	194	204	intestinal	intestinal	JJ	B-NP
O	205	213	bacteria	bacteria	NNS	I-NP
O	214	216	on	on	IN	B-PP
O	217	220	the	the	DT	B-NP
O	221	232	development	development	NN	I-NP
O	233	235	of	of	IN	B-PP
B-Pathological_formation	236	251	atherosclerotic	atherosclerotic	JJ	B-NP
I-Pathological_formation	252	259	lesions	lesion	NNS	I-NP
O	260	265	using	use	VBG	B-VP
O	266	280	apolipoprotein	apolipoprotein	NN	B-NP
O	281	282	E	E	NN	I-NP
O	283	284	(	(	(	O
O	284	288	ApoE	ApoE	NN	B-NP
O	288	289	)	)	)	O
O	289	290	-	-	HYPH	B-NP
O	290	299	deficient	deficient	JJ	I-NP
O	300	308	knockout	knockout	NN	I-NP
O	309	313	mice	mouse	NNS	I-NP
O	313	314	.	.	.	O

O	315	322	METHODS	METHODS	NNS	B-NP
O	322	323	:	:	:	O

O	324	327	The	The	DT	B-NP
O	328	339	experiments	experiment	NNS	I-NP
O	340	344	were	be	VBD	B-VP
O	345	354	performed	perform	VBN	I-VP
O	355	357	on	on	IN	B-PP
O	358	362	ApoE	ApoE	NN	B-NP
O	362	363	-	-	HYPH	O
O	363	364	/	/	SYM	B-NP
O	364	365	-	-	SYM	B-NP
O	365	366	-	-	HYPH	B-NP
O	366	375	deficient	deficient	JJ	I-NP
O	376	381	mouse	mouse	NN	I-NP
O	382	388	strain	strain	NN	I-NP
O	389	394	C57BL	C57BL	NN	I-NP
O	394	395	/	/	SYM	B-NP
O	395	396	6	6	CD	I-NP
O	396	397	,	,	,	O
O	398	402	bred	breed	VBN	B-VP
O	403	408	under	under	IN	B-PP
O	409	413	germ	germ	NN	B-NP
O	413	414	-	-	HYPH	O
O	414	418	free	free	JJ	O
O	419	420	(	(	(	O
O	420	422	GF	GF	NN	B-NP
O	422	423	)	)	)	O
O	424	434	conditions	condition	NNS	B-NP
O	435	438	for	for	IN	B-PP
O	439	442	two	two	CD	B-NP
O	443	454	generations	generation	NNS	I-NP
O	455	457	or	or	CC	B-PP
O	458	463	under	under	IN	B-PP
O	464	476	conventional	conventional	JJ	B-NP
O	477	487	conditions	condition	NNS	I-NP
O	488	492	with	with	IN	B-PP
O	493	500	defined	define	VBN	B-NP
O	501	511	microflora	microflora	NN	I-NP
O	512	513	(	(	(	O
O	513	515	CV	CV	NN	B-NP
O	515	516	)	)	)	O
O	516	517	.	.	.	O

O	518	521	The	The	DT	B-NP
O	522	526	mice	mouse	NNS	I-NP
O	527	531	were	be	VBD	B-VP
O	532	535	fed	feed	VBN	I-VP
O	536	537	a	a	DT	B-NP
O	538	546	standard	standard	JJ	I-NP
O	547	550	low	low	JJ	I-NP
O	551	562	cholesterol	cholesterol	NN	I-NP
O	563	567	diet	diet	NN	I-NP
O	568	570	or	or	CC	I-NP
O	571	582	cholesterol	cholesterol	NN	I-NP
O	582	583	-	-	HYPH	B-NP
O	583	587	rich	rich	JJ	I-NP
O	588	592	diet	diet	NN	I-NP
O	593	596	for	for	IN	B-PP
O	597	598	3	3	CD	B-NP
O	598	599	-	-	HYPH	I-NP
O	599	600	4	4	CD	I-NP
O	601	607	months	month	NNS	I-NP
O	607	608	.	.	.	O

O	609	611	We	We	PRP	B-NP
O	612	619	studied	study	VBD	B-VP
O	620	623	the	the	DT	B-NP
O	624	635	development	development	NN	I-NP
O	636	638	of	of	IN	B-PP
O	639	647	advanced	advance	VBN	B-NP
B-Pathological_formation	648	655	lesions	lesion	NNS	I-NP
O	656	658	in	in	IN	B-PP
O	659	662	the	the	DT	B-NP
B-Multi-tissue_structure	663	671	thoracic	thoracic	JJ	I-NP
O	672	675	and	and	CC	I-NP
B-Multi-tissue_structure	676	685	abdominal	abdominal	JJ	I-NP
I-Multi-tissue_structure	686	691	aorta	aorta	NN	I-NP
O	692	694	by	by	IN	B-PP
O	695	707	histological	histological	JJ	B-NP
O	707	708	,	,	,	I-NP
O	709	721	morphometric	morphometric	JJ	I-NP
O	722	725	and	and	CC	I-NP
O	726	744	immunohistological	immunohistological	JJ	I-NP
O	745	752	methods	method	NNS	I-NP
O	752	753	.	.	.	O

O	754	761	RESULTS	RESULTS	NNS	B-NP
O	761	762	:	:	:	O

O	763	777	Conventionally	Conventionally	RB	B-NP
O	778	784	reared	rear	VBN	I-NP
O	785	789	ApoE	ApoE	NN	I-NP
O	789	790	-	-	HYPH	O
O	790	791	/	/	SYM	O
O	791	792	-	-	HYPH	O
O	793	797	mice	mouse	NNS	B-NP
O	798	799	(	(	(	O
O	799	809	containing	contain	VBG	B-VP
O	810	812	no	no	DT	B-NP
O	813	823	pathogenic	pathogenic	JJ	I-NP
B-Multi-tissue_structure	824	834	intestinal	intestinal	JJ	I-NP
O	835	845	microbiota	microbiota	NN	I-NP
O	845	846	)	)	)	O
O	847	850	and	and	CC	O
O	851	854	fed	feed	VBN	B-VP
O	855	856	a	a	DT	B-NP
O	857	865	standard	standard	JJ	I-NP
O	866	869	low	low	JJ	I-NP
O	870	881	cholesterol	cholesterol	NN	I-NP
O	882	886	diet	diet	NN	I-NP
O	887	889	in	in	IN	B-PP
O	890	898	contrast	contrast	NN	B-NP
O	899	901	to	to	TO	B-PP
O	902	903	a	a	DT	B-NP
O	904	908	high	high	JJ	I-NP
O	909	920	cholesterol	cholesterol	NN	I-NP
O	921	925	diet	diet	NN	I-NP
O	926	929	did	do	VBD	B-VP
O	930	933	not	not	RB	I-VP
O	934	941	develop	develop	VB	I-VP
B-Pathological_formation	942	957	atherosclerotic	atherosclerotic	JJ	B-NP
I-Pathological_formation	958	964	aortic	aortic	JJ	I-NP
I-Pathological_formation	965	972	plaques	plaque	NNS	I-NP
O	972	973	.	.	.	O

O	974	976	In	In	IN	B-PP
O	977	985	contrast	contrast	NN	B-NP
O	985	986	,	,	,	O
O	987	991	ApoE	ApoE	NN	B-NP
O	991	992	-	-	HYPH	O
O	992	993	/	/	SYM	O
O	993	994	-	-	HYPH	O
O	995	999	mice	mouse	NNS	B-NP
O	1000	1006	reared	rear	VBN	B-VP
O	1007	1012	under	under	IN	B-PP
O	1013	1021	germfree	germfree	JJ	B-NP
O	1022	1032	conditions	condition	NNS	I-NP
O	1033	1036	for	for	IN	B-PP
O	1037	1038	2	2	CD	B-NP
O	1039	1050	generations	generation	NNS	I-NP
O	1051	1054	and	and	CC	O
O	1055	1058	fed	feed	VBD	B-VP
O	1059	1060	a	a	DT	B-NP
O	1061	1064	low	low	JJ	I-NP
O	1065	1076	cholesterol	cholesterol	NN	I-NP
O	1077	1081	diet	diet	NN	I-NP
O	1082	1091	exhibited	exhibit	VBD	B-VP
B-Pathological_formation	1092	1107	atherosclerotic	atherosclerotic	JJ	B-NP
I-Pathological_formation	1108	1115	plaques	plaque	NNS	I-NP
O	1116	1118	in	in	IN	B-PP
O	1119	1122	the	the	DT	B-NP
B-Multi-tissue_structure	1123	1128	aorta	aorta	NN	I-NP
O	1128	1129	.	.	.	O

O	1130	1144	Characteristic	Characteristic	JJ	B-NP
O	1145	1150	lipid	lipid	NN	I-NP
O	1151	1161	deposition	deposition	NN	I-NP
O	1162	1166	with	with	IN	B-PP
O	1167	1171	foam	foam	NN	B-NP
B-Cell	1172	1177	cells	cell	NNS	I-NP
O	1178	1181	and	and	CC	O
B-Cell	1182	1193	macrophages	macrophage	NNS	B-NP
O	1194	1197	was	be	VBD	B-VP
O	1198	1203	found	find	VBN	I-VP
O	1204	1206	in	in	IN	B-PP
O	1207	1212	their	their	PRP$	B-NP
B-Multi-tissue_structure	1213	1221	arterial	arterial	JJ	I-NP
I-Multi-tissue_structure	1222	1227	walls	wall	NNS	I-NP
O	1227	1228	.	.	.	O

O	1229	1239	CONCLUSION	CONCLUSION	NN	B-NP
O	1239	1240	:	:	:	O

O	1241	1243	In	In	IN	B-PP
O	1244	1252	contrast	contrast	NN	B-NP
O	1253	1255	to	to	TO	B-PP
O	1256	1259	the	the	DT	B-NP
O	1260	1267	absence	absence	NN	I-NP
O	1268	1270	of	of	IN	B-PP
B-Pathological_formation	1271	1286	atherosclerotic	atherosclerotic	JJ	B-NP
I-Pathological_formation	1287	1294	plaques	plaque	NNS	I-NP
O	1295	1297	in	in	IN	B-PP
O	1298	1312	conventionally	conventionally	RB	B-NP
O	1313	1319	reared	rear	VBN	I-NP
O	1320	1324	ApoE	ApoE	NN	I-NP
O	1324	1325	-	-	HYPH	I-NP
O	1325	1334	deficient	deficient	JJ	I-NP
O	1335	1339	mice	mouse	NNS	I-NP
O	1339	1340	,	,	,	O
O	1341	1345	germ	germ	NN	B-NP
O	1345	1346	-	-	HYPH	O
O	1346	1350	free	free	JJ	B-NP
O	1351	1355	ApoE	ApoE	NN	I-NP
O	1355	1356	-	-	HYPH	O
O	1356	1357	/	/	SYM	O
O	1357	1358	-	-	HYPH	O
O	1359	1363	mice	mouse	NNS	B-NP
O	1364	1373	consuming	consume	VBG	B-VP
O	1374	1377	the	the	DT	B-NP
O	1378	1382	same	same	JJ	I-NP
O	1383	1386	low	low	JJ	I-NP
O	1387	1398	cholesterol	cholesterol	NN	I-NP
O	1399	1407	standard	standard	NN	I-NP
O	1408	1412	diet	diet	NN	I-NP
O	1413	1422	developed	develop	VBD	B-VP
B-Pathological_formation	1423	1438	atherosclerotic	atherosclerotic	JJ	B-NP
I-Pathological_formation	1439	1446	plaques	plaque	NNS	I-NP
O	1447	1449	in	in	IN	B-PP
O	1450	1453	the	the	DT	B-NP
B-Multi-tissue_structure	1454	1459	aorta	aorta	NN	I-NP
O	1459	1460	.	.	.	O

O	1461	1472	Differences	Difference	NNS	B-NP
O	1473	1475	in	in	IN	B-PP
B-Pathological_formation	1476	1491	atherosclerotic	atherosclerotic	JJ	B-NP
I-Pathological_formation	1492	1499	plaques	plaque	NNS	I-NP
O	1500	1507	between	between	IN	B-PP
O	1508	1510	GF	GF	NN	B-NP
O	1511	1514	and	and	CC	O
O	1515	1517	CV	CV	NN	B-NP
O	1518	1522	ApoE	ApoE	NN	I-NP
O	1522	1523	-	-	HYPH	O
O	1523	1524	/	/	SYM	O
O	1524	1525	-	-	HYPH	O
O	1526	1530	mice	mouse	NNS	B-NP
O	1531	1534	are	be	VBP	B-VP
O	1535	1538	not	not	RB	O
O	1539	1541	so	so	RB	B-ADJP
O	1542	1550	apparent	apparent	JJ	I-ADJP
O	1551	1555	when	when	WRB	B-ADVP
O	1556	1560	mice	mouse	NNS	B-NP
O	1561	1564	are	be	VBP	B-VP
O	1565	1568	fed	feed	VBN	I-VP
O	1569	1570	a	a	DT	B-NP
O	1571	1575	high	high	JJ	I-NP
O	1576	1587	cholesterol	cholesterol	NN	I-NP
O	1588	1592	diet	diet	NN	I-NP
O	1592	1593	.	.	.	O

O	1594	1597	Our	Our	PRP$	B-NP
O	1598	1606	findings	finding	NNS	I-NP
O	1607	1611	thus	thus	RB	B-ADVP
O	1612	1620	document	document	VBP	B-VP
O	1621	1624	the	the	DT	B-NP
O	1625	1635	protective	protective	JJ	I-NP
O	1636	1642	effect	effect	NN	I-NP
O	1643	1645	of	of	IN	B-PP
O	1646	1656	microbiota	microbiota	NN	B-NP
O	1657	1658	(	(	(	O
O	1658	1667	commensal	commensal	JJ	B-NP
O	1668	1676	bacteria	bacteria	NNS	I-NP
O	1676	1677	)	)	)	O
O	1678	1680	on	on	IN	B-PP
O	1681	1696	atherosclerosis	atherosclerosis	NN	B-NP
O	1697	1708	development	development	NN	I-NP
O	1708	1709	.	.	.	O

